ET occurring in NPM1 ‐mutated AML during molecular complete remission: A further potential evolution of a complex disease

Documenti analoghi

• Evolution from an antecedent chronic myeloid malignancy does not impact survival outcomes in NPM1‐mutated AML
  di: Elliot Smith, et al.
  Pubblicazione: (2024)
• Post‐Relapse Outcomes of Older Patients With NPM1‐Mutated AML Are Favorable With Allo Transplant in Second Remission
  di: Avraham Frisch, et al.
  Pubblicazione: (2024)
• Unveiling myeloid transformation: T‐LGLL with eosinophilia masking myeloid‐associated STAT5B mutation culminating in AML
  di: Qianze Dong, et al.
  Pubblicazione: (2024)
• Molecular remission uncoupled with complete haematological response in polycythaemia vera treatment with ropeginterferon alfa‐2b
  di: Shanshan Suo, et al.
  Pubblicazione: (2024)
• The IKZF1 N159S mutation is associated with poor outcome and a distinct molecular profile in adult patients with AML
  di: Sebastian Stasik, et al.
  Pubblicazione: (2025)